349 related articles for article (PubMed ID: 18301795)
1. 5-HT7 receptor antagonists as a new class of antidepressants.
Mnie-Filali O; Lambás-Señas L; Zimmer L; Haddjeri N
Drug News Perspect; 2007 Dec; 20(10):613-8. PubMed ID: 18301795
[TBL] [Abstract][Full Text] [Related]
2. [Mechanism of action of antidepressants and therapeutic perspectives].
Bourin M; David DJ; Jolliet P; Gardier A
Therapie; 2002; 57(4):385-96. PubMed ID: 12422559
[TBL] [Abstract][Full Text] [Related]
3. 5-HT7, neurogenesis and antidepressants: a promising therapeutic axis for treating depression.
Nandam LS; Jhaveri D; Bartlett P
Clin Exp Pharmacol Physiol; 2007; 34(5-6):546-51. PubMed ID: 17439430
[TBL] [Abstract][Full Text] [Related]
4. Clinical data on the role of serotonin in the mechanism(s) of action of antidepressant drugs.
Price LH; Charney DS; Delgado PL; Goodman WK; Krystal JH; Woods SW; Heninger GR
J Clin Psychiatry; 1990 Apr; 51 Suppl():44-50; discussion 51-2. PubMed ID: 2182616
[TBL] [Abstract][Full Text] [Related]
5. Long-term adaptive changes induced by serotonergic antidepressant drugs.
Faure C; Mnie-Filali O; Haddjeri N
Expert Rev Neurother; 2006 Feb; 6(2):235-45. PubMed ID: 16466303
[TBL] [Abstract][Full Text] [Related]
6. Emerging drugs for major depressive disorder.
Kennedy SH; Rizvi SJ
Expert Opin Emerg Drugs; 2009 Sep; 14(3):439-53. PubMed ID: 19637989
[TBL] [Abstract][Full Text] [Related]
7. Effects of lurasidone in behavioral models of depression. Role of the 5-HT₇ receptor subtype.
Cates LN; Roberts AJ; Huitron-Resendiz S; Hedlund PB
Neuropharmacology; 2013 Jul; 70():211-7. PubMed ID: 23416039
[TBL] [Abstract][Full Text] [Related]
8. Glutamate-based antidepressants: 20 years on.
Skolnick P; Popik P; Trullas R
Trends Pharmacol Sci; 2009 Nov; 30(11):563-9. PubMed ID: 19837463
[TBL] [Abstract][Full Text] [Related]
9. In vivo actions of atypical antipsychotic drug on serotonergic and dopaminergic systems.
Meltzer HY; Huang M
Prog Brain Res; 2008; 172():177-97. PubMed ID: 18772033
[TBL] [Abstract][Full Text] [Related]
10. A therapeutic role for cannabinoid CB1 receptor antagonists in major depressive disorders.
Witkin JM; Tzavara ET; Davis RJ; Li X; Nomikos GG
Trends Pharmacol Sci; 2005 Dec; 26(12):609-17. PubMed ID: 16260047
[TBL] [Abstract][Full Text] [Related]
11. 5HT1A receptors and pharmacotherapy. Is serotonin receptor down-regulation linked to the mechanism of action of antidepressant drugs?
Stahl S
Psychopharmacol Bull; 1994; 30(1):39-43. PubMed ID: 7972628
[TBL] [Abstract][Full Text] [Related]
12. Neuropharmacology of second-generation antipsychotic drugs: a validity of the serotonin-dopamine hypothesis.
Kuroki T; Nagao N; Nakahara T
Prog Brain Res; 2008; 172():199-212. PubMed ID: 18772034
[TBL] [Abstract][Full Text] [Related]
13. Stress- and antidepressant treatment-induced modifications of 5-HT₇ receptor functions in the rat brain.
Tokarski K; Bobula B; Grzegorzewska-Hiczwa M; Kusek M; Hess G
Pharmacol Rep; 2012; 64(6):1305-15. PubMed ID: 23406741
[TBL] [Abstract][Full Text] [Related]
14. Strategies for producing faster acting antidepressants.
Adell A; Castro E; Celada P; Bortolozzi A; Pazos A; Artigas F
Drug Discov Today; 2005 Apr; 10(8):578-85. PubMed ID: 15837601
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological blockade of 5-HT7 receptors as a putative fast acting antidepressant strategy.
Mnie-Filali O; Faure C; Lambás-Señas L; El Mansari M; Belblidia H; Gondard E; Etiévant A; Scarna H; Didier A; Berod A; Blier P; Haddjeri N
Neuropsychopharmacology; 2011 May; 36(6):1275-88. PubMed ID: 21326194
[TBL] [Abstract][Full Text] [Related]
16. [New perspectives of the mechanism of action of antidepressants arised from genomic theory of depression].
Cereseto M; Ferrero A
Vertex; 2003; 14(51):30-5. PubMed ID: 12690407
[TBL] [Abstract][Full Text] [Related]
17. Crosstalk between the norepinephrine and serotonin systems and its role in the antidepressant response.
Blier P
J Psychiatry Neurosci; 2001; 26 Suppl(Suppl):S3-10. PubMed ID: 11590967
[TBL] [Abstract][Full Text] [Related]
18. Beyond serotonin.
Meltzer HY
J Clin Psychiatry; 1991 May; 52 Suppl():58-62. PubMed ID: 2030105
[TBL] [Abstract][Full Text] [Related]
19. Rational site-directed pharmacotherapy for major depressive disorder.
Blier P
Int J Neuropsychopharmacol; 2014 Jul; 17(7):997-1008. PubMed ID: 23745670
[TBL] [Abstract][Full Text] [Related]
20. [Affective disorders and antidepressant drugs: Therapeutic innovations].
Fakra E; Azorin JM; Adida M; Da Fonseca D; Kaladjian A; Pringuey D
Encephale; 2010 Dec; 36 Suppl 6():S183-7. PubMed ID: 21237354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
